Scinovex
review Open AccessTop 1% cited

The Diabetes Mellitus–Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation

International Journal of Molecular Sciences · 2020 · Vol. 21(5) · pp. 1835–1835
Anastasia V. PoznyakAndrey V. GrechkoPaolo PoggioVeronika A. MyasoedovaValentina AlfieriAlexander N. Orekhov

Abstract

Diabetes mellitus comprises a group of carbohydrate metabolism disorders that share a common main feature of chronic hyperglycemia that results from defects of insulin secretion, insulin action, or both. Insulin is an important anabolic hormone, and its deficiency leads to various metabolic abnormalities in proteins, lipids, and carbohydrates. Atherosclerosis develops as a result of a multistep process ultimately leading to cardiovascular disease associated with high morbidity and mortality. Alteration of lipid metabolism is a risk factor and characteristic feature of atherosclerosis. Possible links between the two chronic disorders depending on altered metabolic pathways have been investigated in numerous studies. It was shown that both types of diabetes mellitus can actually induce atherosclerosis development or further accelerate its progression. Elevated glucose level, dyslipidemia, and other metabolic alterations that accompany the disease development are tightly involved in the pathogenesis of atherosclerosis at almost every step of the atherogenic process. Chronic inflammation is currently considered as one of the key factors in atherosclerosis development and is present starting from the earliest stages of the pathology initiation. It may also be regarded as one of the possible links between atherosclerosis and diabetes mellitus. However, the data available so far do not allow for developing effective anti-inflammatory therapeutic strategies that would stop atherosclerotic lesion progression or induce lesion reduction. In this review, we summarize the main aspects of diabetes mellitus that possibly affect the atherogenic process and its relationship with chronic inflammation. We also discuss the established pathophysiological features that link atherosclerosis and diabetes mellitus, such as oxidative stress, altered protein kinase signaling, and the role of certain miRNA and epigenetic modifications.

Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes and associated disordersDiabetes mellitusDyslipidemiaMedicineInflammationLipid metabolismInternal medicineDiseasePathogenesisEndocrinologyInsulin

MeSH terms

AnimalsDiabetes MellitusGlucoseHumansInflammationInsulin ResistanceLipidsOxidative StressAtherosclerosis

Funding

  • Russian Science Foundation
Citations
1,096
FWCI
75.93
field-weighted impact
References
89
Percentile
100%
vs. same field & year
Citations per year
References
Pathogenesis of Atherosclerosis
Journal of the American College of Cardiology · 2006 · 1,707 citations
Metabolic origins and clinical significance of LDL heterogeneity
Journal of Lipid Research · 2002 · 890 citations
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Experimental Biology and Medicine · 2008 · 593 citations
Oxidative Stress and Diabetic Complications
Circulation Research · 2010 · 5,316 citations
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
New England Journal of Medicine · 2008 · 7,704 citations
Follow-up Report on the Diagnosis of Diabetes Mellitus
Diabetes Care · 2003 · 3,828 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.